AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05808387 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Resveratrol
Description: Trans-resveratrol, 1000 mg daily for 90 days
Study NCT05808387 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Starch, 1000 mg daily for 90 days
Study NCT06537453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Care
Description: Participants will go through Virtual hospital programs following the processes established by these programs in Alberta.
Study NCT06184984 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Metabolic availability of methionine in mung beans
Description: Each participant will randomly receive 7 different levels of methionine provided as free amino acids and cooked mung beans.
Study NCT05426551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual isotope method
Description: The digestibility of amino acids will be determined within each arm by the collection of ileal digesta owing to naso-ileal intubation device and by plasma samples with the dual isotope method.
Study NCT05662072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor imagery
Description: Mental imagery of respiratory exercises
Study NCT05015348 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fish oil with omega-3 PUFA
Description: 3.6g per day fish oil with omega-3 PUFA (EPA+DHA)
Study NCT05015348 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: palm oil as placebo
Study NCT05662072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action observation
Description: Action observation of respiratory exercises
Study NCT05662072 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Intervention
Description: Placebo observation
Study NCT04603066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron 16 mg with Tariquidar
Description: In randomized order, each participant will receive two IV infusions of ondansetron, 3 weeks apart; one with placebo (D5W), and one with tariquidar (4mg/kg dose in D5W) administered IV over 60 minutes. Ondansetron will be diluted in 100mL 0.9% normal saline, and tariquidar will be diluted in 500mL D5W.
Study NCT04603066 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ondansetron 16 mg with Placebo
Description: In randomized order, each participant will receive two IV infusions of ondansetron, 3 weeks apart; one with placebo (D5W), and one with tariquidar (4mg/kg dose in D5W) administered IV over 60 minutes. Ondansetron will be diluted in 100mL 0.9% normal saline, and tariquidar will be diluted in 500mL D5W.
Study NCT06310733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LGG
Description: Participants will take 10 mL of a suspension of freeze-dried LGG ATCC53103 in excipients in an aqueous solution, supplied in a 10-mL dark bottle with a delivery cap.
Study NCT06310733 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will take 10 mL of an identical aqueous solution in appearance and taste but without LGG, supplied in a 10-mL dark bottle.
Study NCT05994872 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reverse drilling technique
Description: A standard hamstring autograft procedure was performed using reverse drilling technique to prepare bone tunnel.
Study NCT05994872 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Traditional extraction drilling
Description: A standard hamstring autograft procedure was performed using traditional extraction drilling to prepare bone tunnel.
Study NCT05399082 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Forceps biopsy
Description: Biopsy forceps used to collect tissue
Study NCT04860648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lung ultrasound
Description: doctors treat the patients combining the Lus results and clinical practice
Study NCT05162924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation
Description: Manual therapy technique applied by a chiropractor in the form of a high-velocity low-amplitude force to the lumbopelvic spine
Study NCT05162924 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo spinal manipulation consisting in the application by a chiropractor of a lower-velocity lower-amplitude force to gluteal muscles in a non-intentional direction
Study NCT06291168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic Manipulation (HVLA - High Velocity Low Amplitude)
Description: Participants in the groups receiving DNS will be asked to hold the lower leg in the side lying position with the lower leg in the extended position and to clamp the upper leg to the lower leg with hip and knee flexion. During the application, the HLVA technique will be applied once by positioning the hypothenar part of the physiotherapist's hand on the transverse process of the lumbar vertebra where tenderness is felt by palpation and vertebral subluxation is thought to be present.~After determining that the movement disorder of the sacroiliac joints of the participant is caused by the impaired movement of the ilium in the posterior and inferior direction or the impaired movement of the ilium in the anterior and superior direction, the participant will be asked to take a side lying position.HVLA spinal manipulation was performed for less than one second from posterior to anterior, inferior to superior and medial to lateral directions.
Study NCT06291168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga-Based Exercise Program
Description: Yoga treatment includes exercise, respiration, balance and coordination, and stretching and will be performed by a physiotherapist with yoga certification. Patients will be evaluated before treatment, two weeks later, after treatment (at the end of the 8th week) and at the end of the 12th week after treatment (control).~Yoga exercises will be practiced with the classical yoga program, divided into groups of 3-4 people, for 8 weeks, 2 days a week, 60 minutes a day.~It will be applied as a yoga session program including breathing and warm-up exercises, suyanamaskar, various relaxation techniques and asanas.
Study NCT06291168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Exercises
Description: Spinal stabilization exercises for the lumbar region will be given in 3 phases following the protocol given to the chiropractic manipulation group. The exercises will be performed two days a week with a physiotherapist. In order to facilitate the memorization and follow-up of the exercises, short videos will be made to facilitate compliance with the exercises by showing the exercises and methods of prevention of low back pain. Individuals will be called to the hospital two days a week for 8 weeks.
Study NCT06197178 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LCAR-G08 cells
Description: Prior to infusion of the LCAR-G08, subjects will receive a conditioning premedication regimen consisting of cyclophosphamide and fludarabine.
Study NCT06395779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuromuscular Exercise Group
Description: A 12-week Neuromuscular exercise program consisting of sensorimotor system training, postural stability and control, global and local joint stabilization, balance training, muscle strength, breathing, and functional movement patterns will be created for the participants in Group 1.
Study NCT06395779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance Therapy Group
Description: Participants in Group 2 will be given dance training by a dance instructor in the gym for 1 hour a day, 2 days a week, for a total of 12 weeks. In dance therapy practices, simple and basic movements are appropriate to the level of the participants, and special attention will be paid to the rhythm of the music not being fast. Latin dances were applied to the participants; selected rumba, merengue, bachata, and salsa movements. Dance therapy will start with a warm-up exercise (10 minutes), then dance exercises will be applied and the activity will end with a cool-down exercise (10 minutes).
Study NCT05762211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pooled allogeneic fecal microbiotherapy
Description: Capsule for oral use
Study NCT05762211 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral use
Study NCT06574048 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline placebo
Description: IV saline bolus
Study NCT06574048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 10mg IV Dexamethasone
Study NCT05735652 — intervention group
Intervention type: DEVICE
Intervention: SpaceOAR Hydrogel
Description: The SpaceOAR System is an in-situ formed absorbable hydrogel that is administered transperineally (with transrectal ultrasound guidance) between the prostate and rectum
Study NCT05965700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVG-291
Description: A once daily injection
Study NCT05965700 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NVG-291
Description: A once daily injection
Study NCT06239168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Citrus extract
Description: As described in experimental arm
Study NCT06239168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: As described in comparator arm
Study NCT06138977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powered prosthesis
Description: A powered prosthesis will be used to restore normative leg biomechanics to above-knee amputee participants during different activities of daily life.
Study NCT05411965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003(T)
Description: Test drug (T):BR3003 Boryung Pharmaceutical Co., Ltd.
Study NCT05411965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003B(R1)
Description: Reference drug 1 (R1): BR3003B of Celltrion Pharm, Inc.
Study NCT05411965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003C(R2)
Description: Reference drug 2 (R2): BR3003C of AstraZeneca Korea
Study NCT05653466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented on a schedule determined by an algorithm that relies on the pattern of correct vs. incorrect responses for each item. Items in the active learning state need to be answered correctly a certain number of times before being categorized as learned. Each item must be answered correctly 3 times in a row (immediately, then at one-minute and five-minute intervals) before it is categorized as learned. Then, it will be scheduled at ever-increasing intervals, until answered incorrectly, at which point the item would be returned to the active learning state, requiring three correct responses in a row to return again to the learned expanding interval state.
Study NCT05653466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.
Study NCT06064253 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: health education
Description: adherence to treatment
Study NCT05653466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Item Non-Adaptive Spacing Condition
Description: Each of the 40 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.
Study NCT05733013 — intervention group
Intervention type: OTHER
Intervention: Surveillance Visit
Description: Follow-up visits will be carried out at intervals per usual clinical practice. Tolerance of medication and adverse events will be recorded in every visit.
Study NCT05896293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: kisspeptin 112-121
Description: SC administration of kisspeptin for two weeks (pulsatile, every 60-240 minutes)
Study NCT05896293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leuprolide acetate
Description: Single SC bolus
Study NCT05047211 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous sulfate
Description: one tablet 325 milligrams three times a day
Study NCT05047211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron dextran
Description: 1000 mg intravenous infusion
Study NCT04806243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib Pill&Camrelizumab
Description: Regorafenib，80 mg，QD，Q3w Camrelizumab，200 mg，IV，Q3w
Study NCT05395078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy treatment along with thoracic extension exercises
Description: Thoracic Extension Exercises (2 sets of 10 reps each/day). This exercise program will target thoracic spine extension and trunk muscle flexibility. A specialized program of thoracic extension in sitting, in prone lying, in quadruped position, on foam roller, wall angle stretch, corner stretch + hot pack (10 min) + Trapezius and Levator Scapulae stretching + Myofascial Release + Thoracic spinal mobilization (3 sets of 3 reps each/day). A total of 45 minutes session three times a week on alternate days for 3 weeks.~Assessment will be done at baseline, on the end of 3rd week and for long term effects at the end of 6th week.
Study NCT05395078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy treatment along with thoracic stabilization exercises
Description: Thoracic Stabilization Exercises (2 sets of 10 reps each/day). This exercise program will target thoracic musculature, static and dynamic thoracic posture. A specialized program of Draw- in and chin tucks in crook lying, prone, sitting and standing, prone chin- tuck elevation exercises with arm at sides, arms behind head or overhead (4) + hot pack (10 min) + Trapezius and Levator Scapulae stretching + Myofascial Release + Thoracic spinal mobilization (3 sets of 3 reps each/day). A total of 45 minutes session three times a week on alternate days for 3 weeks. Assessment will be done at baseline, on the end of 3rd week and for long term effects at the end of 6th week.
Study NCT06658704 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supervised exercise in a group setting
Description: Participants are invited to a 16 week exercise intervention at a private fitness center after they have received their PaP. The exercise, including a variety of aerobic and resistance training, is performed in a group setting starting with one session per week for the first two weeks and then two sessions per week for week 3-16.
Study NCT06658704 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care (Physical activity on Prescription)
Description: Participants are prescribed a Physical activity on Prescription (PaP) which means that they will have a motivational interview with a physiotherapist regarding increased physical activity. The physiotherapist will then prescribe a individualized PaP with the goal to increase weekly physical activity that the participant are instructed to adhere to for the remainder of the study. A follow-up session is also included after 16 weeks.
Study NCT06658704 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual care (Physical activity on Prescription)
Description: Participants are prescribed a Physical activity on Prescription (PaP) which means that they will have a motivational interview with a physiotherapist regarding increased physical activity. The physiotherapist will then prescribe a individualized PaP with the goal to increase weekly physical activity that the participant are instructed to adhere to for the remainder of the study. A follow-up session is also included after 16 weeks.
Study NCT05199701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mammography
Description: Hologic pre-market Mammography
Study NCT05468684 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: there are no interventions planned, we observe the patients in a cohort study which is named inception cohort study because we test participants before the condition develops.
Study NCT06240936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Cycle of breathing
Description: Active Cycle of Breathing Techniques will be given to group A. In Active cycle of breathing exercises, breathing control, thoracic expansion and forced expiration technique will be applied. 3-4 sets of exercise ,10-15 mint, 4 times per week for 4 weeks.
Study NCT06240936 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Cycle of breathing
Description: Active Cycle of Breathing Techniques will be given to group A. In Active cycle of breathing exercises, breathing control, thoracic expansion and forced expiration technique will be applied. 3-4 sets of exercise ,10-15 mint, 4 times per week for 4 weeks.
Study NCT06240936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Cycle of breathing with Acapella
Description: Acapella device will be used along active cycle of breathing techniques to group B. 3-4 sets ,10 mints foe acapella training ,15 -20 munts ,4 times per week for 4 weeks.~This technique is active form of therapy in which patient uses its own energy on request to aid in treatment.
Study NCT06720285 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: nerve block with 0.5% ropivacaine
Description: Compared to active comparator arm, the experimental arm received the same procedure except in the analgesia maintenance which was performed by nerve block of the scalp using 0.5% ropivacaine. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.
Study NCT06720285 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia and opioids (fentanyl, propofol, rocuronium)
Description: Compared to experimental arm, the active comparator arm received the same procedure except in the analgesia maintenance which was performed through continuous fentanyl infusion. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.
Study NCT06720285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: General anesthesia and opioids (fentanyl, propofol, rocuronium)
Description: Compared to experimental arm, the active comparator arm received the same procedure except in the analgesia maintenance which was performed through continuous fentanyl infusion. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.
Study NCT05099497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using Practice Facilitators to Support Physicians
Description: Utilize practice facilitators to empower family physicians to contact those who remain unvaccinated have better access to the COVID-19 vaccine.
Study NCT04795648 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfluthrin
Description: Passive emanator with formulated transfluthrin
Study NCT04795648 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Passive emanator with formulated inert ingredients
Study NCT06275789 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge preservation
Description: Premolar tooth will be extracted flapless and ridge preservation procedure with bone grafting material will be done.
Study NCT06275789 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Premolar tooth will be extracted flapless and ridge preservation procedure with bone grafting material will be done.
Study NCT04970147 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Gastrostomy care bundle
Description: Gastrostomy care bundle
Study NCT05110417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyridostigmine Bromide 60 Milligrams (mg)
Description: One tablet will be provided to patients during the second visit.
Study NCT06449430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sedation with propofol
Description: Sedation with propofol
Study NCT06449430 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spinal analgesia with bupivacaine
Description: Spinal analgesia with bupivacaine
Study NCT06349369 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: tDCS is a non-invasive neuromodulation technique that has gained attention for its potential to influence neural activity and address cognitive and functional deficits in individuals with schizophrenia. It involves applying a weak direct electrical current to the scalp, which can increase or decrease the excitability of underlying brain regions.
Study NCT06349369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: tDCS is a non-invasive neuromodulation technique that has gained attention for its potential to influence neural activity and address cognitive and functional deficits in individuals with schizophrenia. It involves applying a weak direct electrical current to the scalp, which can increase or decrease the excitability of underlying brain regions.